HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients; kaposi’s sarcoma, primary effusion lymphoma (which is a rare type of nonHodgkin lymphoma affecting the body cavities), and multicentric Castleman’s disease. HHV 8 is the likely etiological agent of Kaposi’s sarcoma.
HHV8
Catalog No: 5256
Categories: Primary Antibodies, IVD - Outside U.S. Market, RUO - For U.S. Market
Tags: Concentrated, H
Description
Additional information
Clone | LN53 |
---|---|
Isotype | IgG3 |
Immunogen | Recombinant protein corresponding to the latent nuclear antigen-1 molecule of HHV8. |
Species | Rat |
Cellular Localization | Nuclear |
Positive Control Tissue | Karposi sarcoma |
Pretreatment | EDTA Buffer pH 8.0 |
Incubation & Temperature | 30 min @ RT |
Intended Use | IVD, RUO |
Detection System | PolyVue Plus – Two Step Detection System or Montage PolyVue Plus Auto Detection System for Montage 360 System |
Description/Type | Rat Monoclonal Antibody |
Format | Tissue Culture Supernatant |
DATASHEETS & SDS
REFERENCES
REFERENCES
- i) Ablashi et al. Clinc Microbiol Reviews 15: 439, 2002
- ii) Dupin et al. Proc. Natl. Acad. Sci. USA 96: 4546, 1999.
- iii) Kellam et al. J Virol 73: 5149, 1999.
Reviews (0)
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.